Literature DB >> 29908963

Nonfunctional mutant Wrn protein leads to neurological deficits, neuronal stress, microglial alteration, and immune imbalance in a mouse model of Werner syndrome.

Chin Wai Hui1, Marie-Kim St-Pierre1, Jérôme Detuncq1, Lucie Aumailley2, Marie-Julie Dubois3, Vanessa Couture1, Daniel Skuk1, André Marette3, Jacques P Tremblay1, Michel Lebel4, Marie-Ève Tremblay5.   

Abstract

Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-family DNA helicase, WRN. Mice lacking part of the helicase domain of the WRN orthologue exhibit many phenotypic features of WS, including metabolic abnormalities and a shorter lifespan. Yet, little is known about the impact of WRN mutations on the central nervous system in both humans and mouse models of WS. In the current study, we have performed a longitudinal behavioral assessment on mice bearing a Wrn helicase deletion. Behavioral tests demonstrated a loss of motor activity and coordination, reduction in perception, increase in repetitive behavior, and deficits in both spatial and social novelty memories in Wrn mutant mice compared to age-matched wild type mice. These neurological deficits were associated with biochemical and histological changes in the brain of aged Wrn mutant mice. Microglia, resident immune cells that regulate neuronal plasticity and function in the brain, were hyper-ramified in multiple regions involved with the behavioral deficits of Wrn mutant mice. Furthermore, western analyses indicated that Wrn mutant mice exhibited an increase of oxidative stress markers in the prefrontal cortex. Supporting these findings, electron microscopy studies revealed increased cellular aging and oxidative stress features, among microglia and neurons respectively, in the prefrontal cortex of aged Wrn mutant mice. In addition, multiplex immunoassay of serum identified significant changes in the expression levels of several pro- and anti-inflammatory cytokines. Taken together, these findings indicate that microglial dysfunction and neuronal oxidative stress, associated with peripheral immune system alterations, might be important driving forces leading to abnormal neurological symptoms in WS thus suggesting potential therapeutic targets for interventions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavior; Brain; Cytokines; Microglia; Mouse aging; Neuron; Oxidative stress; Werner syndrome

Mesh:

Substances:

Year:  2018        PMID: 29908963     DOI: 10.1016/j.bbi.2018.06.007

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  8 in total

1.  Investigating Microglial Ultrastructural Alterations and Intimate Relationships with Neuronal Stress, Dystrophy, and Degeneration in Mouse Models of Alzheimer's Disease.

Authors:  Marie-Kim St-Pierre; Micaël Carrier; Victor Lau; Marie-Ève Tremblay
Journal:  Methods Mol Biol       Date:  2022

2.  Novel microglia-mediated mechanisms underlying synaptic loss and cognitive impairment after traumatic brain injury.

Authors:  Karen Krukowski; Amber Nolan; McKenna Becker; Katherine Picard; Nathalie Vernoux; Elma S Frias; Xi Feng; Marie-Eve Tremblay; Susanna Rosi
Journal:  Brain Behav Immun       Date:  2021-08-14       Impact factor: 19.227

Review 3.  Protective Mechanisms Against DNA Replication Stress in the Nervous System.

Authors:  Clara Forrer Charlier; Rodrigo A P Martins
Journal:  Genes (Basel)       Date:  2020-06-30       Impact factor: 4.096

4.  Ultrastructural characterization of dark microglia during aging in a mouse model of Alzheimer's disease pathology and in human post-mortem brain samples.

Authors:  Marie-Kim St-Pierre; Micaël Carrier; Fernando González Ibáñez; Eva Šimončičová; Marie-Josée Wallman; Luc Vallières; Martin Parent; Marie-Ève Tremblay
Journal:  J Neuroinflammation       Date:  2022-09-27       Impact factor: 9.587

5.  Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis.

Authors:  Adham Fani Maleki; Giulia Cisbani; Nataly Laflamme; Paul Prefontaine; Marie-Michele Plante; Joanie Baillargeon; Manu Rangachari; Jean Gosselin; Serge Rivest
Journal:  Neurotherapeutics       Date:  2021-01-21       Impact factor: 7.620

6.  Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer's disease.

Authors:  Adham Fani Maleki; Giulia Cisbani; Marie-Michèle Plante; Paul Préfontaine; Nataly Laflamme; Jean Gosselin; Serge Rivest
Journal:  J Neuroinflammation       Date:  2020-07-22       Impact factor: 8.322

Review 7.  Microglial subtypes: diversity within the microglial community.

Authors:  Vassilis Stratoulias; Jose Luis Venero; Marie-Ève Tremblay; Bertrand Joseph
Journal:  EMBO J       Date:  2019-08-02       Impact factor: 11.598

8.  Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington's disease pathology.

Authors:  Julie C Savage; Marie-Kim St-Pierre; Micaël Carrier; Hassan El Hajj; Sammy Weiser Novak; Maria Gabriela Sanchez; Francesca Cicchetti; Marie-Ève Tremblay
Journal:  J Neuroinflammation       Date:  2020-04-02       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.